Related references
Note: Only part of the references are listed.Interaction between cytokines, cannabinoids and the nervous system
Lucie Jean-Gilles et al.
IMMUNOBIOLOGY (2010)
Cannabinoids Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Inhibit the Lipopolysaccharide-activated NF-κB and Interferon-β/STAT Proinflammatory Pathways in BV-2 Microglial Cells
Ewa Kozela et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
An endocannabinoid tone limits excitotoxicity in vitro and in a model of multiple sclerosis
F. Loria et al.
NEUROBIOLOGY OF DISEASE (2010)
Interactions between the anxiogenic effects of CB1 gene disruption and 5-HT3 neurotransmission
Eva Mikics et al.
BEHAVIOURAL PHARMACOLOGY (2009)
Endocannabinoids in the Treatment of Mood Disorders: Evidence from Animal Models
Francis Rodriguez Bambico et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation
Guy A. Cabral et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2009)
Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis
Yannick Marchalant et al.
NEUROBIOLOGY OF DISEASE (2009)
CB2 cannabinoid receptor agonists attenuate TNF-alpha-induced human vascular smooth muscle cell proliferation and migration
M. Rajesh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies
A. Arevalo-Martin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
CNS immune surveillance and neuroinflammation: Endocannabinoids keep control
Susanne A. Wolf et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
The endocannabinoid system in peripheral lymphocytes as a mirror of neuroinflammatory diseases
Diego Centonze et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Mechanisms of control of neuron survival by the endocannabinoid system
Ismael Galve-Roperh et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Hypermetabolic syndrome as a consequence of repeated psychological stress in mice
Maren Depke et al.
ENDOCRINOLOGY (2008)
Stress mediators regulate brain prostaglandin synthesis and peroxisome proliferator-activated receptor-γ activation after stress in rats
Borja Garcia-Bueno et al.
ENDOCRINOLOGY (2008)
Endocannabinoid 2-arachidonoylglycerol protects neurons by limiting COX-2 elevation
Jian Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice
Ester Aso et al.
JOURNAL OF NEUROCHEMISTRY (2008)
The role of the endocannabinoid system in the regulation of hypothalamic-pituitary-adrenal axis activity
D. Cota
JOURNAL OF NEUROENDOCRINOLOGY (2008)
Ajulemic acid, a synthetic cannabinoid acid, induces an antiinflammatory profile of eicosanoids in human synovial cells
Judith A. Stebulis et al.
LIFE SCIENCES (2008)
Stress as a neuroinflammatory condition in brain:: Damaging and protective mechanisms
Borja Garcia-Bueno et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2008)
Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors
S. E. O'Sullivan
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 increases glutamate uptake through overexpression of GLT1 and EAAC1 glutamate transporter subtypes in rat frontal cerebral cortex
Pasqualina Castaldo et al.
NEUROPHARMACOLOGY (2007)
Endocannabinoids and traumatic brain injury
R. Mechoulam et al.
MOLECULAR NEUROBIOLOGY (2007)
Modulation of PPAR activity via phosphorylation
Katherine A. Burns et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARγ target gene involved in neuroprotection
Cristina Romera et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration
John C. Ashton et al.
CURRENT NEUROPHARMACOLOGY (2007)
Effects of peroxisome proliferator-activated receptor gamma agonists on brain glucose and glutamate transporters after stress in rats
Borja Garcia-Bueno et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells
Katarzyna Maresz et al.
NATURE MEDICINE (2007)
Δ9-Tetrahydrocannabinol protects hippocampal neurons from excitotoxicity
Glenna L. Gilbert et al.
BRAIN RESEARCH (2007)
Regional differentiation of the medial prefrontal cortex in regulating adaptive responses to acute emotional stress
Jason J. Radley et al.
JOURNAL OF NEUROSCIENCE (2006)
Signaling pathways involved in the cardioprotective effects of cannabinoids
Philippe Lepicier et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2006)
CB, receptor selective activation inhibits β-amyloid-induced iNOS protein expression in C6 cells and subsequently blunts tau protein hyperphosphorylation in co-cultured neurons
Giuseppe Esposito et al.
NEUROSCIENCE LETTERS (2006)
Characterization of the neuroprotective effect of the cannabinoid agonist WIN-55212 in an in vitro model of hypoxic-ischemic brain damage in newborn rats
David Fernandez-Lopez et al.
PEDIATRIC RESEARCH (2006)
Stress susceptibility predicts the severity of immune depression and the failure to combat bacterial infections in chronically stressed mice
C. Kiank et al.
BRAIN BEHAVIOR AND IMMUNITY (2006)
Immobilization stress induces cell death through production of reactive oxygen species in the mouse cerebral cortex
YJ Lee et al.
NEUROSCIENCE LETTERS (2006)
CB1 cannabinoid receptors are involved in neuroprotection via NF-κB inhibition
D Panikashvili et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2005)
Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1β-stimulated human astrocytes
WS Sheng et al.
GLIA (2005)
Defective adult neurogenesis in CB1 cannabinoid receptor knockout mice
KL Jin et al.
MOLECULAR PHARMACOLOGY (2004)
Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis
S Patel et al.
ENDOCRINOLOGY (2004)
Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors
L Urigüen et al.
NEUROPHARMACOLOGY (2004)
The role of endogenous cannabinoids in the hypothalamo-pituitary-adrenal axis regulation: in vivo and in vitro studies in CB1 receptor knockout mice
I Barna et al.
LIFE SCIENCES (2004)
CB1 cannabinoid receptors and on-demand defense against excitotoxicity
G Marsicano et al.
SCIENCE (2003)
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis
G Pryce et al.
BRAIN (2003)
Induction of cyclooxygenase-2 accounts for restraint stress-induced oxidative status in rat brain
JLM Madrigal et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Role of endogenous cannabinoids in synaptic signaling
TF Freund et al.
PHYSIOLOGICAL REVIEWS (2003)
A mechanism converting psychosocial stress into mononuclear cell activation
A Bierhaus et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Emerging roles of PPARs in inflammation and immunity
RA Daynes et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1
G Marsicano et al.
JOURNAL OF NEUROCHEMISTRY (2002)
The increase in TNF-α levels is implicated in NF-κB activation and inducible nitric oxide synthase expression in brain cortex after immobilization stress
JLM Madrigal et al.
NEUROPSYCHOPHARMACOLOGY (2002)
Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain
JLM Madrigal et al.
NEUROPSYCHOPHARMACOLOGY (2001)
Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: Involvement of eicosanoids
YH Chang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2001)
Inducible nitric oxide synthase expression in brain cortex after acute restraint stress is regulated by nuclear factor kappa B-mediated mechanisms
JLM Madrigal et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Share Paper
